Family Med Medical News about Risk Uterine Neoplasms Fertility Agents

Your Unread Messages

See All

Tracy Hampton, PhD

Clinical Trial Watch

Study Establishes Standard Treatment for Rare Pediatric Brain Cancer

Roberta Buell, MBA
Medicare Final Rule for 2010

Dorothy J. Schirf, MD

Technology Advances

Radiosurgery Trial Sparks Optimism for Early Lung Cancer

Sara Hartley

Cancer Science

Using Embryonic Stem Cells to Test Breast Cancer Genes

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

2. Omega-3 fatty acids for bipolar disorder

3. Is folic acid good for everyone

4. ACS Releases Guidelines for HPV Vaccination

5. Vitamin D - A review Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Use of Fertility Drugs and Risk of Uterine Cancer: Results From a Large Danish Population-based Cohort Study
American Journal of Epidemiology, 11/04/09

Jensen A et al. – Ever use of any fertility drug was not associated with uterine cancer risk. However, ever use of gonadotropins (follicle–stimulating hormone and human menopausal gonadotropin) increased uterine cancer risk; the risk was primarily observed after 10 years of follow–up. Furthermore, uterine cancer risk increased with number of cycles of use for clomiphene and human chorionic gonadotropin but not for other gonadotropins. Use of gonadotropin–releasing hormone analogs was not associated with risk. Gonadotropins, and possibly clomiphene and human chorionic gonadotropin, may increase the risk of uterine cancer, with higher doses and longer follow–up leading to greater risk.

<< Previous
Usefulness of inspiratory capacity measurement in COPD patients...

Next >>
Outcomes using exhaled nitric oxide measurements as an adjunct to...